PT  - JOURNAL ARTICLE
AU  - Atrah, H I
AU  - Crawford, R J
AU  - Dow, B C
AU  - Mitchell, R
TI  - Safety of intravenous immunoglobulin treatment.
AID  - 10.1136/jcp.38.10.1192
DP  - 1985 Oct 01
TA  - Journal of Clinical Pathology
PG  - 1192--1193
VI  - 38
IP  - 10
4099  - http://jcp.bmj.com/content/38/10/1192.short
4100  - http://jcp.bmj.com/content/38/10/1192.full
SO  - J Clin Pathol1985 Oct 01; 38
AB  - In a prospective clinical and biochemical study of 16 patients treated with high doses of an immunoglobulin product that had been modified for intravenous use by mild pepsin treatment at pH 4 no evidence of hepatitis could be found. This contrasts with recent reports that intravenous immunoglobulin products can apparently transmit non-A, non-B hepatitis.